Hudson Bay Capital Management LP - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$5,362,000
+103.1%
5,380,000
+100.0%
0.03%
-25.6%
Q3 2020$2,640,000
+0.3%
2,690,0000.0%0.04%
-15.2%
Q2 2020$2,631,000
+4.3%
2,690,0000.0%0.05%
-27.0%
Q1 2020$2,522,000
-1.6%
2,690,0000.0%0.06%
+10.5%
Q4 2019$2,562,000
+4.6%
2,690,0000.0%0.06%
-16.2%
Q3 2019$2,450,000
-0.7%
2,690,0000.0%0.07%
+19.3%
Q2 2019$2,467,000
-1.0%
2,690,0000.0%0.06%
+78.1%
Q1 2019$2,493,0002,690,0000.03%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders